Skip to main content
Fig. 3 | Journal of Pharmaceutical Health Care and Sciences

Fig. 3

From: Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot study

Fig. 3

Changes in the pain degree by Pain Vision® at CIPN development as evaluated by a medical professional (CTCAE ver. 4.0). Indicated changes in the pain degree by Pain Vision® at CIPN development as evaluated by a medical professional (CTCAE ver. 4.0). The bar indicates the pain degree by Pain Vision® as means ± standard deviations before chemotherapy and after CIPN development (grades 1 and 2). A comparison of both values was performed with Fisher’s LSD test

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us